A PYMNTS Company

Australia: Court dismisses Pfizer of anti-competitive case

By  |  February 25, 2015

The federal court has dismissed a case against Pfizer Australia which claimed the pharmaceutical giant misused its market power and engaged in anti-competitive conduct in the way it supplied one of its blockbuster drugs to pharmacists.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The Australian Competition and Consumer Commission (alleged that in offering heavy discounts just before losing its patent over Lipitor, Pfizer had aimed to deter or prevent competitors entering the market.

    The commission also alleged Pfizer had engaged in anti-competitive conduct.

    But on Wednesday Justice Geoffrey Flick dismissed the case, saying there was not enough evidence to prove the claims.

     

    Full Content: The Wall Street Journal

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.